Anti-Inflammatory and Tissue Regenerative Effects of Topical Treatment with Ozonated Olive Oil/Vitamin E Acetate in Balanitis Xerotica Obliterans

Molecules. 2018 Mar 13;23(3):645. doi: 10.3390/molecules23030645.

Abstract

Balanitis xerotica obliterans (BXO) is a chronic inflammatory skin disorder, considered the male genital variant of lichen sclerosus. Anti-inflammatory drugs are commonly used in BXO. We evaluated the effects of an innovative formulation of ozonated olive oil with vitamin E acetate (OZOILE®) on the inflammatory status and tissue remodeling in male children with BXO. The mRNA transcripts of proteins involved either in inflammation or in dynamics of tissue regeneration were analyzed by quantitative real-time PCR, in foreskins affected by BXO removed from patients untreated or treated with OZOILE® cream for 7 days before circumcision. We found a significant reduction in mRNA levels of IL-1β, TNF-α, INF-γ, transglutaminase 2 and NOS2 in foreskins treated with OZOILE® in comparison to untreated ones (p < 0.001). No significant differences were observed in NF-κB activation in the specimens obtained from treated and untreated patients. Hence, OZOILE® treatment up-regulated hypoxia-inducible factor (HIF)-1alpha, vascular endothelial growth factor (VEGF) and E-cadherin gene expression (p < 0.001). The treatment with OZOILE® showed effective results in children affected by BXO by reducing the inflammatory process and stimulating mechanisms for tissue regeneration of the foreskin. A randomized clinical trial on a large number of children affected by BXO might be useful to verify the efficacy of topical treatment with OZOILE®.

Keywords: HIF-1 alpha; antioxidant therapy; balanitis xerotica obliterans; inflammation; ozonated olive oil; tissue regeneration; vitamin E acetate.

Publication types

  • Observational Study

MeSH terms

  • Administration, Topical
  • Adolescent
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / pharmacology
  • Balanitis Xerotica Obliterans / drug therapy*
  • Balanitis Xerotica Obliterans / genetics
  • Child
  • Circumcision, Male
  • Cytokines / drug effects
  • Cytokines / genetics*
  • Drug Combinations
  • GTP-Binding Proteins / genetics
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation / drug effects
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Male
  • Nitric Oxide Synthase Type II / genetics
  • Olive Oil / administration & dosage*
  • Olive Oil / pharmacology
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases / genetics
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / genetics
  • Vitamin E / administration & dosage*
  • Vitamin E / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Drug Combinations
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Olive Oil
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Vitamin E
  • NOS2 protein, human
  • Nitric Oxide Synthase Type II
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • GTP-Binding Proteins